Natural Killer Cell Therapy Industry Research Report 2023

Natural Killer Cell Therapy Industry Research Report 2023


Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Highlights

The global Natural Killer Cell Therapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest

Product Type Insights

Global markets are presented by Natural Killer Cell Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Natural Killer Cell Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Natural Killer Cell Therapy segment by Type

NK Cell Therapies
NK Cell Directed Antibodies

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Natural Killer Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Natural Killer Cell Therapy market.
Natural Killer Cell Therapy Segment by Application

Cancer
Gastrointestinal Diseases
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Natural Killer Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Killer Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Natural Killer Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Natural Killer Cell Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Killer Cell Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Natural Killer Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Frequently Asked Questions

What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Natural Killer Cell Therapy by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Cancer
2.3.3 Gastrointestinal Diseases
2.3.4 Others
2.4 Assumptions and Limitations
3 Natural Killer Cell Therapy Breakdown Data by Type
3.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2018-2023)
3.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2023-2028)
4 Natural Killer Cell Therapy Breakdown Data by Application
4.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2018-2023)
4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Natural Killer Cell Therapy Market Perspective (2018-2029)
5.2 Global Natural Killer Cell Therapy Growth Trends by Region
5.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2018-2023)
5.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2024-2029)
5.3 Natural Killer Cell Therapy Market Dynamics
5.3.1 Natural Killer Cell Therapy Industry Trends
5.3.2 Natural Killer Cell Therapy Market Drivers
5.3.3 Natural Killer Cell Therapy Market Challenges
5.3.4 Natural Killer Cell Therapy Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Natural Killer Cell Therapy Players by Revenue
6.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2018-2023)
6.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2018-2023)
6.2 Global Natural Killer Cell Therapy Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Natural Killer Cell Therapy Head office and Area Served
6.4 Global Natural Killer Cell Therapy Players, Product Type & Application
6.5 Global Natural Killer Cell Therapy Players, Date of Enter into This Industry
6.6 Global Natural Killer Cell Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Natural Killer Cell Therapy Market Size (2018-2029)
7.2 North America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Natural Killer Cell Therapy Market Size by Country (2018-2023)
7.4 North America Natural Killer Cell Therapy Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Natural Killer Cell Therapy Market Size (2018-2029)
8.2 Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Natural Killer Cell Therapy Market Size by Country (2018-2023)
8.4 Europe Natural Killer Cell Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2018-2029)
9.2 Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2018-2023)
9.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Natural Killer Cell Therapy Market Size (2018-2029)
10.2 Latin America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Natural Killer Cell Therapy Market Size by Country (2018-2023)
10.4 Latin America Natural Killer Cell Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2018-2029)
11.2 Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2018-2023)
11.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Detail
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Detail
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Detail
11.3.2 Affimed Business Overview
11.3.3 Affimed Natural Killer Cell Therapy Introduction
11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Detail
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Detail
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Detail
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.6.5 Fate Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Detail
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Detail
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.8.5 Kiadis Pharma Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Detail
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.9.5 Nkarta Therapeutics Recent Development
11.10 NantKwest
11.10.1 NantKwest Company Detail
11.10.2 NantKwest Business Overview
11.10.3 NantKwest Natural Killer Cell Therapy Introduction
11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.10.5 NantKwest Recent Development
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Natural Killer Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Natural Killer Cell Therapy Revenue Market Share by Type (2018-2023)
Table 7. Global Natural Killer Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Natural Killer Cell Therapy Revenue Market Share by Type (2024-2029)
Table 9. Global Natural Killer Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Natural Killer Cell Therapy Revenue Market Share by Application (2018-2023)
Table 11. Global Natural Killer Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Natural Killer Cell Therapy Revenue Market Share by Application (2024-2029)
Table 13. Global Natural Killer Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Natural Killer Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Natural Killer Cell Therapy Market Share by Region (2018-2023)
Table 16. Global Natural Killer Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Natural Killer Cell Therapy Market Share by Region (2024-2029)
Table 18. Natural Killer Cell Therapy Market Trends
Table 19. Natural Killer Cell Therapy Market Drivers
Table 20. Natural Killer Cell Therapy Market Challenges
Table 21. Natural Killer Cell Therapy Market Restraints
Table 22. Global Top Natural Killer Cell Therapy Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Natural Killer Cell Therapy Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Natural Killer Cell Therapy Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Natural Killer Cell Therapy, Headquarters and Area Served
Table 26. Global Natural Killer Cell Therapy Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Natural Killer Cell Therapy by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Natural Killer Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Natural Killer Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Natural Killer Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Natural Killer Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Natural Killer Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Natural Killer Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. Nektar Therapeutics Company Detail
Table 46. Nektar Therapeutics Business Overview
Table 47. Nektar Therapeutics Natural Killer Cell Therapy Product
Table 48. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 49. Nektar Therapeutics Recent Development
Table 50. Innate Pharma SA Company Detail
Table 51. Innate Pharma SA Business Overview
Table 52. Innate Pharma SA Natural Killer Cell Therapy Product
Table 53. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 54. Innate Pharma SA Recent Development
Table 55. Affimed Company Detail
Table 56. Affimed Business Overview
Table 57. Affimed Natural Killer Cell Therapy Product
Table 58. Affimed Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 59. Affimed Recent Development
Table 60. Chipscreen Biosciences Company Detail
Table 61. Chipscreen Biosciences Business Overview
Table 62. Chipscreen Biosciences Natural Killer Cell Therapy Product
Table 63. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 64. Chipscreen Biosciences Recent Development
Table 65. Glycostem Therapeutics Company Detail
Table 66. Glycostem Therapeutics Business Overview
Table 67. Glycostem Therapeutics Natural Killer Cell Therapy Product
Table 68. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 69. Glycostem Therapeutics Recent Development
Table 70. Fate Therapeutics Company Detail
Table 71. Fate Therapeutics Business Overview
Table 72. Fate Therapeutics Natural Killer Cell Therapy Product
Table 73. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 74. Fate Therapeutics Recent Development
Table 75. Dragonfly Therapeutics Company Detail
Table 76. Dragonfly Therapeutics Business Overview
Table 77. Dragonfly Therapeutics Natural Killer Cell Therapy Product
Table 78. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 79. Dragonfly Therapeutics Recent Development
Table 80. Kiadis Pharma Company Detail
Table 81. Kiadis Pharma Business Overview
Table 82. Kiadis Pharma Natural Killer Cell Therapy Product
Table 83. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 84. Kiadis Pharma Recent Development
Table 85. Nkarta Therapeutics Company Detail
Table 86. Nkarta Therapeutics Business Overview
Table 87. Nkarta Therapeutics Natural Killer Cell Therapy Product
Table 88. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 89. Nkarta Therapeutics Recent Development
Table 90. NantKwest Company Detail
Table 91. NantKwest Business Overview
Table 92. NantKwest Natural Killer Cell Therapy Product
Table 93. NantKwest Revenue in Natural Killer Cell Therapy Business (2017-2022) & (US$ Million)
Table 94. NantKwest Recent Development
Table 95. Nektar Therapeutics Company Information
Table 96. Nektar Therapeutics Business Overview
Table 97. Nektar Therapeutics Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 98. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 99. Nektar Therapeutics Recent Development
Table 100. Innate Pharma SA Company Information
Table 101. Innate Pharma SA Business Overview
Table 102. Innate Pharma SA Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 103. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 104. Innate Pharma SA Recent Development
Table 105. Affimed Company Information
Table 106. Affimed Business Overview
Table 107. Affimed Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 108. Affimed Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 109. Affimed Recent Development
Table 110. Chipscreen Biosciences Company Information
Table 111. Chipscreen Biosciences Business Overview
Table 112. Chipscreen Biosciences Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 113. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 114. Chipscreen Biosciences Recent Development
Table 115. Glycostem Therapeutics Company Information
Table 116. Glycostem Therapeutics Business Overview
Table 117. Glycostem Therapeutics Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 118. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 119. Glycostem Therapeutics Recent Development
Table 120. Fate Therapeutics Company Information
Table 121. Fate Therapeutics Business Overview
Table 122. Fate Therapeutics Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 123. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 124. Fate Therapeutics Recent Development
Table 125. Dragonfly Therapeutics Company Information
Table 126. Dragonfly Therapeutics Business Overview
Table 127. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 128. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 129. Dragonfly Therapeutics Recent Development
Table 130. Kiadis Pharma Company Information
Table 131. Kiadis Pharma Business Overview
Table 132. Kiadis Pharma Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 133. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 134. Kiadis Pharma Recent Development
Table 135. Nkarta Therapeutics Company Information
Table 136. Nkarta Therapeutics Business Overview
Table 137. Nkarta Therapeutics Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 138. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 139. Nkarta Therapeutics Recent Development
Table 140. NantKwest Company Information
Table 141. NantKwest Business Overview
Table 142. NantKwest Natural Killer Cell Therapy Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million)
Table 143. NantKwest Revenue in Natural Killer Cell Therapy Business (2018-2023) & (US$ Million) Portfolio
Table 144. NantKwest Recent Development
Table 145. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Natural Killer Cell Therapy Product Picture
Figure 5. Global Natural Killer Cell Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Natural Killer Cell Therapy Market Share by Type: 2022 VS 2029
Figure 7. NK Cell Therapies Product Picture
Figure 8. NK Cell Directed Antibodies Product Picture
Figure 9. Global Natural Killer Cell Therapy Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Natural Killer Cell Therapy Market Share by Application: 2022 VS 2029
Figure 11. Cancer Product Picture
Figure 12. Gastrointestinal Diseases Product Picture
Figure 13. Others Product Picture
Figure 14. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Natural Killer Cell Therapy Market Share by Region: 2022 VS 2029
Figure 17. Global Natural Killer Cell Therapy Market Share by Players in 2022
Figure 18. Global Natural Killer Cell Therapy Players, Date of Enter into This Industry
Figure 19. Global Top 5 and 10 Natural Killer Cell Therapy Players Market Share by Revenue in 2022
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 21. North America Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Natural Killer Cell Therapy Market Share by Country (2018-2029)
Figure 23. United States Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Natural Killer Cell Therapy Market Share by Country (2018-2029)
Figure 27. Germany Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Natural Killer Cell Therapy Market Share by Country (2018-2029)
Figure 35. China Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Natural Killer Cell Therapy Market Share by Country (2018-2029)
Figure 43. Mexico Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Natural Killer Cell Therapy Market Share by Country (2018-2029)
Figure 47. Turkey Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. UAE Natural Killer Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 51. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 52. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 53. Chipscreen Biosciences Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 54. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 55. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 56. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 57. Kiadis Pharma Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 58. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)
Figure 59. NantKwest Revenue Growth Rate in Natural Killer Cell Therapy Business (2018-2023)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings